Press releasePRNewswire
Aethlon Medical
AEMD · NASDAQ
$5.31+$0.15 (+2.91%)TodayMarket closed ·
Prev close $5.16
Latest news
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
- NewsEvette Mitkov
Aethlon Stock Pulls Back: What's Going On?
- News
Aethlon Medical Q1 2027 Earnings Call Transcript
- NewsShivdeep Dhaliwal
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
- NewsAvi Kapoor
Crude Oil Down 1%; US Pending Home Sales Rise 0.3% In August
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
- Press releaseGlobe Newswire
Four High-Impact Small Caps Enter the Spotlight
- NewsVandana Singh
Aethlon Medical Pivots to Biotechnology with All-Stock Merger
- Press releaseBusiness Wire
AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
- Press releasePRNewswire
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
- Press releasePRNewswire
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
- Press releasePRNewswire
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
- Press releasePRNewswire
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
Aethlon Medical Q4 EPS $0.40 Beats $(2.02) Estimate
- Press releasePRNewswire
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
- News
Earnings Scheduled For June 10, 2026
- Press releasePRNewswire
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
- News
Aethlon Medical Announces Preparedness For Ebola Outbreak, Reiterates Prepared For Investigational Use Of Its Hemopurifier Technology
- Press releasePRNewswire
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
- Press releasePRNewswire
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
- Press releasePRNewswire
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
- Press releasePRNewswire
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
- Press releasePRNewswire
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
- Press releasePRNewswire
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
- Press releasePRNewswire
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
- NewsAvi Kapoor
Why American Eagle Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
- Press releasePRNewswire
Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
- NewsAvi Kapoor
Dow Dips Over 100 Points; US Initial Jobless Claims Increase
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.